NCT06773611 Electronic Register on Advanced Heart Failure and Transplantation di Cuore
| NCT ID | NCT06773611 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-09-04 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-09-04 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to create an electronic registry of patients diagnosed with Advanced Heart Failure or Heart Transplant, starting from 01/01/1985 and to assess the incidence of Advanced Heart Failure and Heart Transplant, and characterize patients affected by the first or undergoing the second procedure, starting from 01/01/1985. The primary outcomes are: * Hospitalization for cardiovascular cause * Death
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Ability to provide informed consent * Diagnosis of Advanced Heart Failure or Heart Transplant Exclusion Criteria: * none
Contact & Investigator
Luciano G Potena, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06773611 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06773611 currently recruiting?
Yes, NCT06773611 is actively recruiting participants. Contact the research team at scompenso.trapiantocuore@aosp.bo.it for enrollment information.
Where is the NCT06773611 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06773611 clinical trial?
NCT06773611 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Luciano G Potena, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.